On the public citation graph
Antibody Reactivity Against SARS-CoV-2 in Adults from the Vancouver Metropolitan Area, Canada
0 signed · 33 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2020.2648openalex-snapshot
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
inferredcites →https://doi.org/10.1007/s10875-021-00997-6openalex-snapshot
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
inferredcites →https://doi.org/10.1016/j.jcv.2020.104572openalex-snapshot
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2
inferredcites →https://doi.org/10.1016/j.tim.2016.03.003openalex-snapshot
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
inferredcites →https://doi.org/10.1016/s0140-6736(20)31304-0openalex-snapshot
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
inferredcites →https://doi.org/10.1016/s0140-6736(20)31482-3openalex-snapshot
SARS-CoV-2 seroprevalence in COVID-19 hotspots
inferredcites →https://doi.org/10.1016/s0140-6736(20)31483-5openalex-snapshot
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
inferredcites →https://doi.org/10.1016/s0140-6736(20)31484-7openalex-snapshot
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
inferredcites →https://doi.org/10.1016/s1084-2756(02)00190-2openalex-snapshot
Inflammation and bronchopulmonary dysplasia
inferredcites →https://doi.org/10.1016/s1473-3099(20)30196-1openalex-snapshot
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
inferredcites →https://doi.org/10.1016/s1473-3099(20)30634-4openalex-snapshot
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
inferredcites →https://doi.org/10.1017/s0950268800048019openalex-snapshot
The time course of the immune response to experimental coronavirus infection of man
inferredcites →https://doi.org/10.1038/s41467-020-15562-9openalex-snapshot
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
inferredcites →https://doi.org/10.1038/s41467-020-17318-xopenalex-snapshot
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
inferredcites →https://doi.org/10.1038/s41586-020-2598-9openalex-snapshot
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
inferredcites →https://doi.org/10.1038/s41591-020-0897-1openalex-snapshot
Antibody responses to SARS-CoV-2 in patients with COVID-19
inferredcites →https://doi.org/10.1086/430355openalex-snapshot
Antigenic Cross‐Reactivity between Severe Acute Respiratory Syndrome–Associated Coronavirus and Human Coronaviruses 229E and OC43
inferredcites →https://doi.org/10.1093/ajcp/aqaa157openalex-snapshot
Clinical Validation and Performance Evaluation of the Automated Vitros Total Anti–SARS-CoV-2 Antibodies Assay for Screening of Serostatus in COVID-19
inferredcites →https://doi.org/10.1093/cid/ciaa900openalex-snapshot
Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
inferredcites →https://doi.org/10.1093/cid/ciaa936openalex-snapshot
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee
inferredcites →https://doi.org/10.1093/cid/ciaa979openalex-snapshot
Magnitude and Kinetics of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity
inferredcites →https://doi.org/10.1093/infdis/jiaa161openalex-snapshot
Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
inferredcites →https://doi.org/10.1101/2020.03.24.006544openalex-snapshot
Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray
inferredcites →https://doi.org/10.1101/2020.07.13.20153148openalex-snapshot
Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020
inferredcites →https://doi.org/10.1126/science.abb2507openalex-snapshot
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
inferredcites →https://doi.org/10.1126/science.abd3871openalex-snapshot
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
inferredcites →https://doi.org/10.1126/science.abd4250openalex-snapshot
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
inferredcites →https://doi.org/10.1126/science.abe1107openalex-snapshot
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
inferredcites →https://doi.org/10.1128/jcm.42.5.2351-2352.2004openalex-snapshot
Antigenic Cross-Reactivity between the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus and Polyclonal Antisera of Antigenic Group I Animal Coronaviruses: Implication for SARS Diagnosis
inferredcites →https://doi.org/10.1155/2006/152612openalex-snapshot
An Outbreak of Human Coronavirus OC43 Infection and Serological Cross‐Reactivity with SARS Coronavirus
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1093/infdis/jiab161openalex-snapshot
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses
inferred← citeshttps://doi.org/10.17269/s41997-021-00531-6openalex-snapshot
SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study
inferred← citeshttps://doi.org/10.2196/65606openalex-snapshot
Developing Requirements for a Standardized System to Return Individual Research Results Back to Study Participants: Narrative Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.